23 February 2018
News and Views
Links and Services
Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the USA, reports this month's Gastroenterology.
Nonalcoholic steatohepatitis (NASH) has been predicted to become the leading indication for liver
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors